Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)
Aurora Cannabis (ACB) jumped about 15% in pre-market trading Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. The White House said no final decisions have been made. Investors responded to the potential for eased penalties and tax burdens. Aurora closed at $4.55 on Dec. 11 and was indicated near $5.30 early Friday.